Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC31H30N6O7S4 |
InChIKeyPRYIVLXRWBBBJH-ULADHSOCSA-N |
CAS Registry174285-71-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | United States | 24 May 1995 |